🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 23 of 173

  1. US 11597773

    CD6 antibody for treatment of T-cell mediated diseases or disorders

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11597727

    Inhibitors of integrin alpha 2 beta 1 and methods of use

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11596909

    System and method for droplet formation and manipulation using ferrofluids

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11597707

    CGAS antagonist compounds

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11597774

    Antibody variable domains and antibody constructs

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11597853

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11598774

    Methods of diagnosis and treatment of Alzheimer's Disease

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11596711

    Solubilization of antigen components for removal from tissues

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11594135

    Methods of CD40 activation and immune checkpoint blockade

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11591319

    Small molecule inducers of autophagy

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11590092

    Skin probiotic

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11591304

    SLC26A3 inhibitors and use thereof

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11590222

    Antibodies that bind human C6 and uses thereof

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11590089

    Beta-2 selective adrenergic receptor agonists

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11590234

    Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11591369

    Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11590171

    Targeted replacement of endogenous T cell receptors

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11591402

    Neutralizing antibodies to the alpha v beta 8 integrin complex for immunotherapy

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11591579

    Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11590085

    Compositions and methods for organ specific delivery of nucleic acids

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11590197

    Agents targeting inhibitor of apoptosis proteins

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11583557

    Placenta-derived multipotent stem cells

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11584760

    Dithio ETP derivatives

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11583541

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11576889

    Methods of identifying and treating patients with HIF-2 inhibitor resistance

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11576883

    L-DOPA microbiome therapy

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11576948

    Long-acting VEGF inhibitors for intraocular neovascularization

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11578313

    CRISPR-Cas effector polypeptides and methods of use thereof

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11576744

    Thermosensitive bio-adhesive hydrogel for removal of ureteral and renal stones

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11576871

    Formulations of cysteamine and cystamine

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11576580

    Apparatus, systems and methods for intraoperative imaging

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11576982

    Nipah virus envelope pseudotyped lentiviruses and methods of their use

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11571538

    Gas delivery devices

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11571389

    Delivery devices and methods for making the same

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11572588

    Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11572377

    Nucleotide analogs

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11572591

    Methods and assays for subtyping Staphylococcus aureus clonal complex 8 strains

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11565000

    Adeno-associated virus virions with variant capsid and methods of use thereof

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11566149

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11564884

    Cationic block polymer micelles for delivery of biological agents

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11565027

    Hydrogel membrane for adhesion prevention

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11564954

    Tumor-delivered multi-target therapeutics for colon cancer

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11564914

    Methods of treating bone loss

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11565001

    Adeno-associated virus virions with variant capsid and methods of use thereof

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11566228

    Hemangio-colony forming cells

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11566253

    Targeted gene demethylation in plants

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11564949

    Ameliorating nervous systems disorders

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11564981

    Vaccine for prevention of necrotic enteritis in poultry

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.